Results 181 to 190 of about 1,598,085 (291)

Optimizing management of stage IV EGFR mutant non‐small cell lung cancer in Asia: An expert opinion

open access: yesInternational Journal of Cancer, Volume 157, Issue 8, Page 1648-1661, 15 October 2025.
What's New? Emerging strategies for the treatment of advanced non‐small cell lung cancer (NSCLC) featuring epidermal growth factor receptor (EGFR) mutations are helping improve patient outcomes. Which strategies are optimal to effectively manage EGFR‐mutant NSCLC, however, remains unclear.
Gee‐Chen Chang   +13 more
wiley   +1 more source

Azithromycin as Host-Directed Therapy for Pulmonary Tuberculosis: A Randomized Pilot Trial. [PDF]

open access: yesJ Infect Dis
Dekkers BGJ   +9 more
europepmc   +1 more source

Prognostic value of combined venoarterial carbon dioxide to arteriovenous oxygen content ratio and lactate measurements in patients with severe trauma: A prospective observational study

open access: yesHong Kong Journal of Emergency Medicine, Volume 32, Issue 5, October 2025.
Abstract Background Trauma remains a significant global health burden, with complex pathophysiological processes necessitating accurate and timely markers for risk assessment. Objective This study investigated the prognostic value of combining the venoarterial carbon dioxide to arteriovenous oxygen content ratio (Pv‐aCO2/Ca‐vO2) with lactate ...
Shen Yongshuai   +4 more
wiley   +1 more source

Complications at Diagnosis of Pediatric Chronic Myeloid Leukemia in Chronic Phase

open access: yesPediatric Blood &Cancer, Volume 72, Issue 10, October 2025.
ABSTRACT Chronic myeloid leukemia (CML) is uncommon during the first two decades of life, resulting in limited experience of pediatricians in handling this leukemia. This is even more true when it comes to managing rare complications at the time of diagnosis.
Nirmalya Roy Moulik   +4 more
wiley   +1 more source

Brucella Pneumonia Mimicking Pulmonary Tuberculosis: A Case Report. [PDF]

open access: yesClin Case Rep
Chapra A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy